Neovasc Inc. Operating CF per Share

Operating CF per Share of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF per Share growth rates and interactive chart. Total operating cash flow in a period divided by the weighted average number of shares outstanding. A company with $100 million in operating cash flow and 10 million weighted average shares will have operating cash flow per share of $10.


Highlights and Quick Summary

  • Operating CF per Share for the quarter ending March 31, 2022 was -2.58 (a 52.36% increase compared to previous quarter)
  • Year-over-year quarterly Operating CF per Share increased by 1.25%
  • Annual Operating CF per Share for 2021 was -10.83 (a -77.5% decrease from previous year)
  • Annual Operating CF per Share for 2020 was -48.13 (a -48.76% decrease from previous year)
  • Annual Operating CF per Share for 2019 was -93.93 (a -75.53% decrease from previous year)
  • Twelve month Operating CF per Share ending March 31, 2022 was -9.51 (a -6.43% decrease compared to previous quarter)
  • Twelve month trailing Operating CF per Share decreased by -18.68% year-over-year
Trailing Operating CF per Share for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-9.51 -10.16 -11.12 -11.7
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF per Share of Neovasc Inc.

Most recent Operating CF per Shareof NVCN including historical data for past 10 years.

Interactive Chart of Operating CF per Share of Neovasc Inc.

Neovasc Inc. Operating CF per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -2.58
2021 -1.69 -2.72 -2.54 -4.45 -10.83
2020 -7.26 -11.13 -14.42 -15.72 -48.13
2019 -22.58 -22.54 -18.56 -38.97 -93.93
2018 -105.52 -72.45 -113.85 -9.05 -383.83
2017 -37688.21 -1262.91 -1216.47 -2035.1 -43617.53
2016 -2489.96 -4117.63 -4092.59 -4038.41 -14738.59
2015 -2288.89 -2387.0 -1924.74 -1383.32 -8185.77
2014 -1227.27 -1545.45 -581.82 -368.42 -3839.71
2013 -568.42 -778.95 -584.21 -483.33 -2389.47
2012 -184.21 -261.11 -338.89 -333.33 -1127.78
2011 -1182.35 -1182.35

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.